The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy

Objective. To evaluate costs, benefits and cost–effectiveness of anti-TNF agents in PsA patients with inadequate response to conventional treatment. Methods. A total of 107 patients, from nine Italian rheumatology centres, with different forms of PsA were given anti-TNF treatment, mainly etanercept...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivieri, I., de Portu, S., Salvarani, C., Cauli, A., Lubrano, E., Spadaro, A., Cantini, F., Cutro, M. S., Mathieu, A., Matucci-Cerinic, M., Pappone, N., Punzi, L., Scarpa, R., Mantovani, L. G.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569134/
https://www.ncbi.nlm.nih.gov/pubmed/18725374
http://dx.doi.org/10.1093/rheumatology/ken320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569134/
https://www.ncbi.nlm.nih.gov/pubmed/18725374
http://dx.doi.org/10.1093/rheumatology/ken320

Ejemplares similares